Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    "mannose-binding lectin deficiency"
Show Display Options
Download search resultsDownload the search results for:
"mannose-binding lectin deficiency" (1 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Withdrawn Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
Conditions: Fever, Sweats, and Hot Flashes;   Infection;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Neutropenia;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Biological: recombinant human mannose-binding lectin

Indicates status has not been verified in more than two years